Abstract. This study investigated the effects of mycelial extract and culture filtrate of Cordyceps sphecocephala J201 on airway hyper-responsiveness, pulmonary immune cell infiltration, and Th2 cytokine expression in animal models of asthma. After Concanavalin A (Con A) activation of mouse primary spleen cells, the IL-4 and IL-13 cytokine expression were significantly decreased in the presence of the mycelial extract and culture filtrate of Cordyceps sphecocephala J201. The asthma model was induced by sensitization to ovalbumin by intraperitoneal (i.p.) injection treatment in mice. The Cordyceps sphecocephala J201 mycelial extract was injected in order to assess the effects of anti-asthmatic activity by comparing lung cell infiltration in ovalbumin-induced asthmatic mice. The results revealed that the increased IL-4, IL-13 and IL-25 expression were controlled by the mycelial extract and culture filtrate of Cordyceps sphecocephala J201, indicating that the extracts reduced the undesirable immune responses and/or cytokine expression exhibited in asthma.
Introduction
It is well known that asthma occurs from the immune system's overreaction to bronchial hyperinflammation, which is increasingly widespread by industrial development and urbanization (1, 2) . Immune cells that trigger asthma in T cells are divided into Th1 and Th2 cells during T cell differentiation (3) . Th1 cells are associated with inflammatory bowel disease (IBD)-related disorders, whereas Th2 cells are associated with autoimmune diseases including asthma (4, 5) .
Research and treatment have given useful asthma preventive medicaments, such as steroid-like drugs for immune disorders (6) . Nevertheless, the drugs could relax the stiff muscles and reduce the activation of immune cells (7) . As the main target of the drug directly induces the reduction of immune hyper-sensitivity reactions, the inflammatory response of cells signaling to the specific target is focused on the treatment of asthma (8, 9) . Interleukin-4 (IL-4) and interleukin-13 (IL-13) are the main immunomodulators to induce the autoimmune responses that are excessively secreted by stimulated Th2 cells, moreover, following that the immunoglobulin E (IgE) and histamine produced by nascent mast cells increases their levels around the bronchial epithelial cells, although these events make the symptoms acute (3) . Asthma, atopic dermatitis, and rhinitis that are known to go through a similar signaling process on hyper-responsive symptoms around the epithelial tissues have similar molecular events (10) (11) (12) .
Cordyceps is traditionally used in Korea, China, and Japan, for the ethnopharmacological treatment of glucose metabolism, cancer, and hypocholesterolemia (13) (14) (15) (16) (17) . Moreover, tyrosinase-inhibitory activities from Cordyceps extracts exhibit a suppressing effect of melanin production (18) . Additionally, anti-depressant, anti-oxidation, hepatoprotective, anti-diabetic, and anti-aging activities from various extracts of Cordyceps exhibited a wide range of bioactivity in vitro, as well as in vivo (19) (20) (21) (22) (23) (24) .
In this study, we found that the mycelial extract and culture filtrate of Cordyceps sphecocephala J201 have potential in alleviating IL-4, and IL-13 activity in vitro, suggesting that the extract exhibits anti-hypersensitivity. Additionally, we discovered that the mycelial extract and culture filtrates from the Cordyceps sphecocephala J201 control immune activities by balancing the Th1/Th2 cell numbers, which is closely associated with the inhibition of asthma symptoms, suggesting that the extracts could be used for the development of preventive anti-asthmatic food biomaterials and/or nutraceuticals. The strain was cultured and isolated in PDA medium (potato dextrose 24 g, agar 15 g, distilled water 1 liter) at 25˚C for 2 weeks. After full growth of mycelial proliferation, the culture supernatants were centrifuged and divided two parts: mycelial extract and culture filtrate (25) . The dried mycelial extract and culture filtrate were then freeze-dried under a vacuum evaporator. The freeze-dried powder was dissolved in phosphate-buffered saline (PBS) prior to use (26) . The mycelial morphology was photographed by a scanning electron microscope, as describe elsewhere (27) .
Materials and methods

Materials
Anti-oxidant activities and cytotoxicity. The DPPH method was used for evaluation of the free radical-scavenging activity of the mycelia extract and culture filtrate. Briefly, a 0.4 mM solution of DPPH in 50% ethanol was prepared and 200 μl of this solution was added to 2 μl of a differential concentration of the samples. The mixture was shaken vigorously and allowed to stand at room temperature for 30 min (28) . Then, the absorbance was measured at 517 nm in a multilabel counter (Victor3, PerkinElmer, Waltham, MA, USA) (13) . Ferric reducing antioxidant power (FRAP) assay was also carried out as describe elsewhere (28) , with a slight modification. Briefly, the FRAP reagent contained 2.5 ml of 10 mM tripyridyltriazine (FRAP) solution in 10 mM HCl plus 2.5 ml of 20 mM FeCl 3 and 25 ml of 0.3 M acetate buffer, pH 3.6, was freshly prepared. The absorption of the reaction mixture was measured at 595 nm. Ascorbic acid was also tested under the same concentration as a standard antioxidant compound. For the cytotoxicity assay, RAW264.7 cells were collected and incubated into 96-well flat-bottom microplates at the counting of 10 4 /well cells. After 24 h, the mycelial extract and culture filtrate and montelukast were treated with 0, 1, 10 and 100 μg/ml for 24 h. Then 10 μl of CCK-8 (Dojindo, Gaithersburg, MD, USA) solution (dehydrogenase activity detection) was added to each well, the plate was incubated for 1 h in the incubator, and the absorbance measured at 450 nm using a microplate reader (Victor3, PerkinElmer) (29) .
Activated spleen cell cultures and cytokine measurement.
Separation of mouse spleen cells in primary culture from Balb/C (male, 10 weeks, Samtaco Korea, Osan, Korea) was carried out as follows: the mouse spleen was dissected and crushed on a clean bench, splenocytes were washed 3 times in tissue culture medium while the fragments were allowed to settle, and then the splenocytes were carefully aspirated from the cellular suspension. Concanavalin A (Con A: 3 μg/ml) was added to activate the total cells following culture for 48 h. Next, various concentrations of aqueous mycelial extract (50 μl/ ml) or culture filtrate (50 μl/ml) of Cordyceps sphecocephala J201 were added for 24 h.
Animal experiment and care. All the procedures were performed in compliance with the Guiding Principles in the Care and Use of Animals (National Research Council, 1996) and in-house guidelines of the University (29) . In brief, sixweek-old male C57BL/6 mice, weighing between 22-25 g, were purchased from Samtaco Korea, and were fed a commercial diet (Samtaco Korea) and water ad libitum. The animals were housed under a 12-h light/dark cycle at a temperature of 22±1˚C and a humidity of 50±5%. We strictly kept the rules and in-house guidelines for animal experiments including ethical care under the guidance of the University Committee. Animals were allowed to acclimate to the laboratory environment for at least one week prior to the experiments. The number of each experimental group was limited to five.
An asthmatic animal model and immunohistochemistry.
The mycelial extract and culture filtrate of Cordyceps sphecocephala J201 was conducted using an ovalbumin-induced animal model for evaluation of anti-asthmatic activity. Mice (C57BL/6, 6 weeks, male) were conducted by spraying with ovalbumin (OVA; 100 μg/ml in saline). In the case of sample treatment, mycelia extract and culture filtrate of Cordyceps sphecocephala J201 were administered 3 times at a volume of 500 μl of each oral dose. After the schedule, the lung was cut out to conduct hematoxylin and eosin (H&E) or Periodic acid Schiff (PAS) staining. Using an optical microscope, we observed the intensity of the symptoms and thereafter evaluated the amount of IL-4, and IL-13 in the plasma or IL-17E in lung tissues was measured using the ELISA method (28) or immunohistochemistry (30) . For the IL-25 expression, we performed an immunohistochemical analysis method (31) with a slight modification.
Statistical analysis. Data were expressed as the means ± standard deviation. Statistical significance was determined by the Student's t-test for independent means using the Microsoft Excel program (32) . The critical level for significance was set at P<0.05 or P<0.001.
Results and Discussion
Cordyceps is an invaluable medicinal mushroom that is called DongChungHaCho (winter worm summer grass) in Korean. It is commonly used to hamper cancer cell growth, and soothe the lung, heart and kidney. For a long time, in Far-East Oriental medicine, it was used to mediate homeostasis in the body, and for the purposes of tonic food and herbal medicine as functional biomaterials. In a previous study, we isolated various Cordyceps and identified one of the strains as Cordyceps sphecocephala J201. The morphology of the selected strain has a classical feature of mycelial growth that is common in entomopathogenic fungus (Fig. 1) . In this study, we optimized the maintenance medium of Cordyceps sphecocephala J201 (data not shown), and investigated the biological activities of the mycelial extract and culture filtrate of that strain, in few strains were studied for anti-asthmatic efficacy and their cytotoxicity of the extracts.
To assess the cytotoxicity of mycelial extract and culture filtrate of Cordyceps sphecocephala J201, we used RAW264.7 cells, and measured the cell proliferation by a CCK-8 kit. As a result, ~20% of cell proliferation was achieved by the addition of culture extract (data not shown). In an earlier study, a component of Cordyceps sphecocephala, the PPP (polysaccharide-peptide complexes) induce DNA fragmentation in the cancer cells, which caused cells to die by caspase-3 and Bcl-2/Bax by expressing various proteins. On the other hand, human hepatocarcinoma (HepG2) and neuroblastoma (SK-N-SH) cells are not known to exhibit toxic effects with treatment (14) . Due to differences between cell populations, Cordyceps sphecocephala J201 cultures did not show any toxicity in the cells, whereas the increase of proliferation exhibits the potential activity of cell growth promotion. In particular, the active ingredient in DongChungHaCho's polysaccharide is known to activate the immune cells (33) .
The immature T helper cell subset has two kinds of cells: Th1 and Th2 cells. These cells depend on the differentiation and development during T cell activation (3). It is evident that if Th1 cells have larger numbers than Th2 cells, it may cause inflammatory bowel diseases (IBDs), Crohn's disease, and ulcerative colitis, whereas, the reverse condition of cell numbers may achieve hyper-responsiveness in asthma, atopic dermatitis, and rhinitis (2). We might measure Th1 or Th2 cells with specific biomarkers, thereafter, specific markers can be regulated through their homeostasis in Th specific cell numbers by preventive treatment. For these reasons, we tested whether or not the extracts from the Cordyceps sphecocephala J201 regulate asthmatic symptoms. We prepared mouse spleen cells, and treated Con A (3 μg/ml) in order to activate the Th2 cells in vitro. As shown in Fig. 3A , there is low amount of IL-4 level (<500 pg/ml) in the control group, but Con A-induced mice exhibited an 8.5-fold increase in the IL-4 expression level. Interestingly, by the treatment of mycelial extract and culture filtrate, the IL-4 level was dramatically reduced to a control level. In the same pattern, the IL-13 activity was also checked. The elevated IL-13 level was also alleviated by the treatment to the control level, indicating that the asthmatic induction was hindered by the extracts of Cordyceps sphecocephala J201 in Th2 cell numbers (Fig. 3A and B) .
The levels of IL-4 and IL-13 in the Th2 cells and in serum are associated with asthmatic symptoms that are the most important phenotype markers in peripheral lung tissues, as well as in serum, during hypersensitivity events (3, 10, 12) . Other expressions, such as T-bet, eotaxin, IgE, ß-hexosaminidase and histamine will also affect asthmatic symptoms in vivo. In order to investigate whether the mycelium extract and culture broth of Cordyceps sphecocephala J201 have potential in alleviating the asthmatic symptoms in vivo, we activated the asthmatic marker levels, such as IL-4 and IL-13, by ovalbumin in mice.
As shown in Materials and methods, we dispersed ovalbumin by aerosolized spraying in mice, and then administered the mycelial extract and culture broth of the Cordyceps sphecocephala J201 to assess the potential in alleviating the asthmatic symptoms in vivo. All mice were sensitized intraperitoneally with 100 μg/head of ovalbumin on days 0 and 12. The mice were re-exposed to aerosolized ovalbumin or saline for 30 min on days 25, 27 and 29. Following treatment with mycelial extract or culture broth of the Cordyceps sphecocephala J201 (50 μg/head) every 2 days for 26 to 30 days, histopathological observations of lung tissues were performed. As a result, hematoxylin and eosin (H&E) staining showed clean tissue in the control group (Fig. 4A) , whereas several immune positive cells were clustered together around the smaller parts of the lungs in the ovalbumin-treated tissues ( Fig. 4B and F; asterisks) . However, Figure 3 . Expressions of cytokines in ovalbumin-induced mice by the treatment of mycelial extract and culture filtrate. Mycelial extract (ME) and culture filtrate (CF) of Cordyceps sphecocephala J201 was treated into ovalbumin-induced mice and analyzed as described in Materials and methods. Measurement of IL-4 (A) and IL-13 (B) content was carried out by ELISA kits. Mouse spleen cells were collected and activated by Concanavalin A (Con A: 3 μg/ml) to activate the total cells as described in detail in Materials and methods. -, Con A alone; ME, mycelium extract; CF, culture filtrate. Data show mean ± SD of triplicate determinations. * Significant difference from Con A alone, P<0.001. ** Significant difference from Con A alone, P<0.001. the number of total immune positive cells from the ovalbumin-challenged group that were treated with the mycelial extract (50 μg/head) had decreased dramatically, as compared with that of ovalbumin-challenged lung tissues (Fig. 4C) . As a positive control, we used montelukast, a worldwide used anti-asthmatic drug, and examined whether the extract has potential in alleviating asthmatic symptoms compared to montelukast. As shown in Fig. 4D and H, the tissues were clear and clean, and there were mere asthmatic signs, which means the OVA-induced lung tissues were protected by the extracts. The above results clearly showed that the anti-asthmatic activities in extracts exert protective effects on OVA-induced damage. Periodic acid-Schiff (PAS) staining show similar aspects (Fig. 4E-H ) to those gained with the H&E staining, while disclosing potent mucus secretions (Fig. 4F,  arrowhead) . We also measured the CD4 + cell content by immunohistopathological analysis, but remarkable changes were not evident in the lung tissues (data not shown).
IL-25 (IL-17E), a novel IL-17 family of immunomodulatory cytokines, is a product of activated Th2 cells. The IL-25 mRNA is expressed in the lung after an engulfed antigen challenge of sensitized mice and the neutralization of the released IL-25 by soluble IL-25 receptor reduced antigen-induced eosinophil/macrophages on airway hyperresponsiveness and inflammation (34) (35) (36) . Next, we evaluated whether or not the ovalbumin-inhaled lung tissues were rescued from IL-25 expression by the treatment of Cordyceps sphecocephala J201 extracts. Immunohistochemical observations revealed that the IL-25 positive cells were significantly dispersed around the ovalbumin-treated tissues ( Fig. 5B; asterisks) , whereas the extract as well as montelukast treatment had dramatically reduced the number of positive cells ( Fig. 5C and D) . IL-25 positive cell counting revealed that the extract treatment of Cordyceps sphecocephala significantly reduced IL-25 secreting cells (Fig. 5F ), suggesting that activated Th2 cells were modulated in balance with the Th1/Th2 cell subset (See 3rd column).
We performed reverse transcription-polymerase chain reaction (RT-PCR) using the primers (TGGCTGAAGTGGA GCTCTGC and TGGCAAGGTGATTGTACACCTG; 464 bp of gene product) for the mRNA expression, and measured the reduced expression (data not shown). Montelukast also inhibited the number of IL-25 positive cells (Fig. 5F, 4th  column) . These results clearly matched the total cell counting numbers which respond to H&E staining (Fig. 5E) , which is one of the classical feature of the OVA-induced inflammation. This was the first data that showed IL-25 levels induced by ovalbumin could be alleviated by the addition of Cordyceps sphecocephala J201 extracts. Fig. 5D shows one of the classical results to the reduction of ovalbumin-induced inflammation.
In conclusion, in this study, we investigated whether the functional biomaterials in the extracts can be effective for asthma, suggesting that mycelial extract and culture filtrate of Cordyceps sphecocephala J201 had the potential of alleviating immune hypersensitivity reactions in asthma. Asthmatic animal models exhibited decreased level of immune responses with T cells that are associated with molecular inflammation. The isolation, purification, characterization of active components/compounds against asthmatic symptoms that are needed for the development of food biomaterials and/or nutraceuticals could be useful for further investigations.
